| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.2M | +97.8% |
| R&D Expense | $16K | -91.0% |
| SG&A Expense | $15.1M | +23.3% |
| Operating Income | -$5.2M | +30.0% |
| Interest Expense | $501K | +0.3% |
| Net Income | -$5.4M | +31.3% |
| EPS (Basic) | -$2.81 | -20.6% |
| EPS (Diluted) | -$2.81 | -20.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.6M | +186.9% |
| Accounts Receivable | $2.4M | +259.6% |
| Inventory | $445K | -7.6% |
| Current Assets | $17.2M | +152.5% |
| Total Assets | $17.5M | +147.8% |
| Current Liabilities | $10.4M | +241.9% |
| Total Liabilities | $10.5M | +8.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.5M | -9.5% |
| Financing Cash Flow | $14.3M | — |
| Stockholders' Equity |
| $7.0M |
| +372.8% |